Hormones Implicated in Perimenopause and Their Associated Symptoms
Perimenopause is primarily driven by declining and erratically fluctuating estradiol levels, decreased progesterone production, and rising follicle-stimulating hormone (FSH), with these hormonal changes directly causing vasomotor symptoms, sleep disruption, mood disturbances, genitourinary symptoms, and metabolic dysfunction.
Primary Hormonal Changes
Estradiol (Estrogen)
The dominant hormonal change is not simply declining estrogen, but erratic fluctuations with paradoxically elevated levels during perimenopause 1. Contrary to traditional understanding, estradiol levels can spike unpredictably, particularly during luteal phases (termed "LOOP" events - luteal out of phase), before eventually declining 1.
Symptoms directly caused by estradiol changes:
Vasomotor symptoms (hot flashes/night sweats): Estrogen deficiency narrows the thermoregulatory zone, causing inappropriate peripheral vasodilation at lower core temperature thresholds. The flash triggers heat loss through increased cutaneous blood flow and perspiration, dropping core temperature and sometimes causing compensatory shivering 2.
Sleep disturbances: Estrogen deficiency increases waking episodes after sleep onset and decreases sleep efficiency. Nocturnal hot flashes correlate directly with sleep disruption, particularly during the first 4 hours of sleep 2.
Genitourinary syndrome of menopause: Declining estradiol causes vulvovaginal atrophy (vaginal dryness, dyspareunia, discomfort with clothing/sitting), plus urinary symptoms including dysuria, frequency, and recurrent infections 2.
Bone loss: Estradiol deficiency increases bone resorption, contributing to fracture risk 2.
Metabolic dysfunction: Estrogen decline drives visceral fat accumulation, loss of lean muscle mass, reduced fat oxidation, impaired metabolic flexibility, and hepatic insulin resistance—even without weight gain 3. This creates a hypometabolic brain state affecting multiple neurological functions 4.
Progesterone
Progesterone levels decline significantly during perimenopause due to anovulatory cycles, short luteal phases, or cycles with inadequate corpus luteum function 1.
Symptoms related to progesterone deficiency:
Mood disturbances: Recent longitudinal studies confirm associations between the menopausal transition and depressed mood, major depressive episodes, and anxiety 2. The loss of progesterone's neuroactive metabolites contributes to these symptoms.
Sleep disruption: Progesterone has sedative properties; its decline compounds sleep problems beyond those caused by hot flashes.
Irregular bleeding: Unopposed estrogen without adequate progesterone causes endometrial instability and unpredictable bleeding patterns 5.
Follicle-Stimulating Hormone (FSH)
FSH levels rise progressively as ovarian follicles deplete and inhibin production declines 6. However, FSH shows marked variability and unpredictability during perimenopause rather than following a smooth upward trend 5.
Clinical significance:
- FSH elevation reflects ovarian aging but is not a reliable predictor of menopause proximity 1.
- High FSH with low inhibin maintains estradiol production until late perimenopause, explaining why estrogen levels remain variable 6.
Inhibin
Inhibin B levels decline progressively, removing negative feedback on FSH while paradoxically helping maintain estradiol levels until just before menopause 6.
Testosterone
Testosterone trajectories show increases in some women during perimenopause, particularly those with elevated insulin levels 7. This may contribute to metabolic changes and mood symptoms.
Secondary Hormonal Factors
Insulin
Elevated fasting insulin during early perimenopause predicts earlier onset and longer duration of hot flashes and night sweats, independent of BMI 7. Higher insulin associates with greater testosterone increases and represents an early marker of metabolic vulnerability 7.
Why These Symptoms Occur: Mechanistic Understanding
The neurological symptoms dominate because estrogen functions as a master regulator of brain metabolism through a network of estrogen receptors controlling energy metabolism via coordinated signaling and transcriptional pathways 4. During perimenopause, this estrogen receptor network becomes uncoupled from the bioenergetic system, creating a hypometabolic state that disrupts:
- Thermoregulation (hot flashes)
- Sleep-wake cycles
- Circadian rhythms
- Sensory processing
- Cognitive function
- Mood regulation 4
The variability is the defining characteristic of perimenopause—hormonal fluctuations are unpredictable rather than following gradual trends, contributing to the visible signs of menstrual irregularities and symptom unpredictability 5.
Clinical Implications
Perimenopause represents a critical window of metabolic vulnerability where adverse changes in body composition, inflammation, and insulin resistance develop—often before significant weight gain occurs 3. These changes increase long-term risk for metabolic syndrome, type 2 diabetes, cardiovascular disease, and potentially neurodegenerative diseases 4, 3.
The hormonal instability affects multiple domains: vasomotor function, sleep, mood, sexual function, cognition, bone density, lipid profiles (particularly HDL and triglycerides), and metabolic health 6, 2.